glp 1 agonist statpearls Frontiers A Closer Look at the

Leading companies such as Novo Nordisk, Eli Lilly, and Sanofi have contributed to market growth with innovative products, including once-weekly formulations to improve patient adherence

High disease prevalence and advanced healthcare infrastructure propel the North America GLP-1 market growth

GLP-1 medications are driving significant shifts in the pharmaceutical market, with soaring demand, rising prescriptions, and multi-billion-dollar growth projections

These results prove that GLP-1-based therapy may reduce inflammation and improve fatty liver disease in animal and human models

Importantly it was not until millions of women had taken the pill over a period of time that researchers began to understand the true nature of their benefits and side effects

As a result, anaesthetists increasingly encounter GLP-1 RAs in daily practice, where decisions affect both surgical safety and long-term outcomes